|
|
||||||||
Clinical Chemistry, Vol 28, 2286-2291, Copyright © 1982 by American Association for Clinical Chemistry
I Vlahos, W MacMahon, D Sgoutas, W Bowers, J Thompson and W Trawick
In this method, we use the Amicon MPS-1 centrifugal ultrafiltration device and the YMB membrane in measuring free testosterone in serum. Two independent assays are combined: total testosterone and the ultrafiltrable fraction of added [3H]testosterone. The unbound fraction is determined in 0.15-0.5 mL ultrafiltrates of 0.6 to 1 mL of variably diluted serum that has been equilibrated with [3H]testosterone at 37 degrees C. The assay is rapid (less than 1 h), practicable (requires 0.6 mL of serum), and reproducible (CV 3.2% within assay, 3.9% between assays). Accuracy was evaluated as the fraction of free testosterone in the ultrafiltrate of dialyzed serum vs that in a prior dialysate; they were the same confirming the validity of the free testosterone measurement. Samples from ostensibly healthy men and women and from hirsute and pregnant women gave results that agreed with those obtained by equilibrium dialysis. Total testosterone concentrations for normal and hirsute women showed considerable overlap, but data on free testosterone concentrations in these populations were better resolved.
The following articles in journals at HighWire Press have cited this article:
![]() |
G. Sartorius, L. P Ly, K. Sikaris, R. McLachlan, and D. J Handelsman Predictive accuracy and sources of variability in calculated free testosterone estimates Ann Clin Biochem, March 1, 2009; 46(2): 137 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P Ly and D. J Handelsman Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays Eur. J. Endocrinol., March 1, 2005; 152(3): 471 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Van Uytfanghe, D. Stockl, J. M. Kaufman, T. Fiers, H. A. Ross, A. P. De Leenheer, and L. M. Thienpont Evaluation of a Candidate Reference Measurement Procedure for Serum Free Testosterone Based on Ultrafiltration and Isotope Dilution-Gas Chromatography-Mass Spectrometry Clin. Chem., November 1, 2004; 50(11): 2101 - 2110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rinaldi, A. Geay, H. Dechaud, C. Biessy, A. Zeleniuch-Jacquotte, A. Akhmedkhanov, R. E. Shore, E. Riboli, P. Toniolo, and R. Kaaks Validity of Free Testosterone and Free Estradiol Determinations in Serum Samples from Postmenopausal Women by Theoretical Calculations Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1065 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Winters, D. E. Kelley, and B. Goodpaster The analog free testosterone assay: are the results in men clinically useful? Clin. Chem., October 1, 1998; 44(10): 2178 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. MacADAMS, R. H. WHITE, and B. E. CHIPPS Reduction of Serum Testosterone Levels During Chronic Glucocorticoid Therapy Ann Intern Med, May 1, 1986; 104(5): 648 - 651. [Abstract] [PDF] |
||||
![]() |
F. E. Schiavone, R. L. Rietschel, D. Sgoutas, and R. Harris Elevated Free Testosterone Levels in Women With Acne Arch Dermatol, October 1, 1983; 119(10): 799 - 802. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |